3

FORM 3 SUBMISSION

Company: Phathom Pharmaceuticals, Inc.
Filed: October 24, 2019
Period of Report: October 24, 2019
Accession Number: 0001209191-19-053993

View Document ↗ View on SEC.gov ↗